Passage Bio is actively advancing its differentiated preclinical research project for Huntington's disease.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The project has made significant progress, and the company expects to complete the selection of clinical candidate drugs in the second half of 2026. This important milestone marks a key step forward for the company in the field of gene therapy research and development in neuroscience. The identification of candidate drugs will lay a solid foundation for subsequent clinical development and is expected to bring new hope for treatment to Huntington's disease patients.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Equities: AI themes support selective overweight – HSBC
FXStreet•2026/11/02 12:39
Travel demand remains strong! Marriott Hotels (MAR.US) Q3 profit and RevPAR exceed expectations, raising full-year outlook
Hotel operator Marriott released its financial report for the third quarter of fiscal year 2026 (ending September 30) before the US stock market opened on Monday.
智通财经•2026/11/02 12:32
Crypto prices
More
Bitcoin
BTC
$77,642.61
-0.16%
Ethereum
ETH
$2,281.91
+1.04%
Tether USDt
USDT
$0.9986
-0.00%
BNB
BNB
$703.6
-1.12%
XRP
XRP
$1.25
-0.06%
USDC
USDC
$0.9997
+0.00%
Solana
SOL
$93.97
-0.78%
TRON
TRX
$0.3164
+1.98%
Hyperliquid
HYPE
$85.39
-2.91%
Zcash
ZEC
$1,245.32
+0.87%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now